Apte’s team revealed that PSC-secreted HGF enhanced the aggressiveness of PDAC via its receptor c-MET on cancer cells, and HGF inhibition resulted in a significant reduction of metastasis in mouse models of PDAC (117, 118). Here, HGF is linked to cancer.